News - Merck Serono, Anti-Arthritics/Rheumatics

Filter

Popular Filters

Merck Serono collaborates with Biopharm GmbH on osteoarthritis research

Merck Serono collaborates with Biopharm GmbH on osteoarthritis research

20-11-2013

Privately-held Biopharma GmbH says it has signed an agreement with Merck Serono, the biopharma subsidiary…

Anti-Arthritics/RheumaticsBiopharm GmbHMerck KGaAMerck SeronoPharmaceuticalResearch

Brazil’s MoH partners with Merck Serono to invest $430 million in bio-pharma production

Brazil’s MoH partners with Merck Serono to invest $430 million in bio-pharma production

08-11-2013

The Brazilian Ministry of Health is managing a series of product development partnerships and the selection…

Anti-Arthritics/RheumaticsBionovisBiotechnologyFinancialMerck KGaAMerck SeronoOncologyProductionSouth America

Merck Serono collaborates with Nordic Bioscience for sprifermin in osteoarthritis

18-03-2013

German drug and chemical major Merck KGaA (MRK: DE) says its Merck Serono division has entered into a…

Anti-Arthritics/RheumaticsMerck KGaAMerck SeronoNordic BiosciencePharmaceuticalResearchsprifermin

Merck Serono expands osteoarthritis collaboration with Ablynx

09-11-2011

Merck Serono, a division of Germany’s Merck KGaA (MRK: DE) has entered into a third agreement with…

AblynxAnti-Arthritics/RheumaticsLicensingMerck SeronoPharmaceuticalResearch

Back to top